氟比洛芬与S-氟比洛芬贴剂在全膝关节置换术后多模式镇痛中的效果:前瞻性随机对照试验
结果显示两种贴剂组在术后第1天和第3天视觉模拟评分均低于对照组,S-氟比洛芬贴剂组术后第7天和第14天膝关节屈曲角度大于对照组,两组均未发生肾功能不全或胃肠道损伤,对照组额外使用口服非甾体抗炎药的比例更高。
要点
- 两种氟比洛芬贴剂均可作为全膝关节置换术后多模式镇痛的有效且安全组成部分。
- S-氟比洛芬贴剂组术后第7天和第14天膝关节屈曲角度优于对照组。
- 对照组额外使用口服非甾体抗炎药的比例更高,贴剂组未发生肾功能不全或胃肠道损伤。
核心结论
- 氟比洛芬贴剂和S-氟比洛芬贴剂作为全膝关节置换术后多模式镇痛的一部分均有效且安全。
研究设计与样本
- 膝关节随机分为氟比洛芬贴剂组(29膝)、S-氟比洛芬贴剂组(27膝)和对照组(23膝,无贴剂)。
- 所有患者采用口服给药、局部关节周围镇痛注射和贴剂进行疼痛管理,贴剂治疗持续14天。
主要发现
- 术后第1天视觉模拟评分:氟比洛芬贴剂组24.4、S-氟比洛芬贴剂组25.0、对照组39.4,两贴剂组均低于对照组。
- 术后第3天视觉模拟评分:氟比洛芬贴剂组25.5、S-氟比洛芬贴剂组23.3、对照组39.3,两贴剂组均低于对照组。
- 术后第7天膝关节屈曲角度:S-氟比洛芬贴剂组89.8°、对照组76.6°,S-氟比洛芬贴剂组大于对照组。
- 术后第14天膝关节屈曲角度:S-氟比洛芬贴剂组98.3°、对照组84.2°,S-氟比洛芬贴剂组大于对照组。
- 对照组额外使用口服非甾体抗炎药的比例更高,未确认肾功能不全或胃肠道损伤,住院时间无组间差异,皮炎仅发生于S-氟比洛芬贴剂组。
临床怎么用
- 全膝关节置换术后可考虑将氟比洛芬贴剂或S-氟比洛芬贴剂纳入多模式镇痛方案以降低疼痛评分。
- 使用S-氟比洛芬贴剂可能有助于改善术后早期膝关节屈曲角度,但需注意皮炎发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total knee arthroplasty (TKA) is an established procedure for knee osteoarthritis. Multimodal analgesia is reportedly more effective for postoperative analgesia. We investigated the efficacy of 2 patches after TKA. METHODS: Seventy-nine knees that underwent unilateral TKA for osteoarthritis were included. Oral administration, local periarticular analgesic injection, and patches were adopted for pain management. The knees were randomly assigned to the flurbiprofen patch (FPP), S-flurbiprofen patch (SFPP), and control (no patch) groups. Patch treatment was continued for 14 days. Pain according to the visual analog scale, knee flexion angle, renal dysfunction, gastrointestinal injury, duration of hospitalization, dermatitis, and the rate of using additional oral nonsteroidal anti-inflammatory drugs were compared (from preoperative to postoperative day 14). RESULTS: The FPP, SFPP, and control groups included 29, 27, and 23 knees, respectively. Visual analog scale was lower in the FPP and SFPP groups than in the control group on days 1 and 3 (day 1: 24.4, 25.0, and 39.4, respectively; day 3: 25.5, 23.3, and 39.3, respectively). Knee flexion angle was larger in the SFPP group than in the control group on days 7 and 14 (day 7: 89.8° and 76.6°, respectively; day 14: 98.3° and 84.2°, respectively). Neither renal dysfunction nor gastrointestinal injury was confirmed. The duration of hospitalization did not differ among the groups. Dermatitis occurred only in the SFPP group. The rate of using additional oral nonsteroidal anti-inflammatory drugs was higher in the control group. CONCLUSION: Both patches were effective and safe as part of multimodal analgesia for postoperative TKA.
引用
- Tsuji M, Kobayashi N, Yukizawa Y, et al. Effect of Flurbiprofen and S-Flurbiprofen Patches on Multimodal Pain Management After Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. J Arthroplasty. 2020. PMID: 32362479. doi:10.1016/j.arth.2020.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。